Softgel Manufacturing Equipment Market Size, Share, Growth, And Industry Analysis By Type (Soft Capsule Encapsulation Machine, Soft Capsule Drying Systems, And Other Auxiliary Devices) By Application (Pharmaceutical, Health Supplements, And Others), Regional Insights And Forecast From 2026 To 2035

• 

  Download Free Sample to learn more about this report

SOFTGEL MANUFACTURING EQUIPMENT MARKET OVERVIEW

The global softgel manufacturing equipment market size is forecasted to be worth USD 0.44 Billion in 2026, expected to achieve USD 1.25 Billion by 2035 with a CAGR of 12.4% during the forecast from 2026 to 2035.

The Softgel Manufacturing Equipment Market is characterized by over 65% of global pharmaceutical companies utilizing softgel encapsulation technology for lipid-based formulations, with more than 40,000 encapsulation machines installed worldwide as of 2024. Approximately 72% of softgel production lines operate with automated systems, reducing manual intervention by 55%. Equipment efficiency rates exceed 85% in high-capacity facilities producing over 300,000 capsules per hour. Around 48% of manufacturers have adopted integrated drying systems, improving moisture control by 30%. The market shows strong penetration in nutraceutical applications, accounting for nearly 58% of total equipment usage globally.

The United States accounts for nearly 28% of the global installed base of softgel manufacturing equipment, with over 8,500 active encapsulation units across pharmaceutical and nutraceutical facilities. Approximately 62% of U.S.-based supplement manufacturers rely on softgel formats, driving demand for advanced machinery. Automation penetration exceeds 75% in large-scale facilities, improving output consistency by 40%. Regulatory compliance standards influence over 90% of equipment purchases, with FDA-aligned systems dominating. Additionally, around 35% of U.S. facilities upgraded to high-speed encapsulation machines between 2021 and 2024, enhancing production capacity by up to 50%.

KEY FINDINGS

LATEST TRENDS

The Softgel Manufacturing Equipment Market Trends indicate significant adoption of automation, with over 70% of new installations incorporating robotic handling systems that improve production efficiency by 45%. Approximately 63% of manufacturers are shifting toward continuous manufacturing systems, reducing batch processing time by 28%. Digital monitoring technologies are now present in 58% of newly installed equipment, enabling real-time performance tracking and reducing downtime by 35%.

Sustainability has become a priority, with nearly 41% of equipment manufacturers integrating energy-efficient components that lower energy consumption by up to 25%. Additionally, water-based cleaning systems are used in 36% of facilities, reducing solvent usage by 20%. The demand for compact and modular equipment has increased by 44%, especially among small and medium-scale manufacturers seeking flexibility. In terms of material compatibility, over 52% of equipment now supports plant-based gelatin alternatives, aligning with the 39% rise in vegan supplement demand. Furthermore, high-speed encapsulation machines capable of producing over 350,000 capsules per hour have seen a 31% increase in adoption. These Softgel Manufacturing Equipment Market Insights highlight the industry's transition toward efficiency, sustainability, and technological advancement.

Download Free Sample to learn more about this report

SOFTGEL MANUFACTURING EQUIPMENT MARKET SEGMENTATION

By Type

Based on the type, the soft gel manufacturing equipment market is segmented into soft capsule encapsulation machines, soft capsule drying systems, and other auxiliary devices.

• Soft Capsule Encapsulation Machines: Soft capsule encapsulation machines account for nearly 49% of the Softgel Manufacturing Equipment Market Share, with over 25,000 units installed globally. These systems operate at speeds of 300,000 to 400,000 capsules per hour, improving production efficiency by 45%. Around 58% of manufacturers use automated encapsulation machines, reducing labor dependency by 35%. Precision levels ensure dosage accuracy within ±2%, which is critical for pharmaceutical compliance. Additionally, 41% of new machines offer multi-fill capabilities, supporting diverse formulations.

• Soft Capsule Drying Systems: Soft capsule drying systems hold approximately 33% of the Softgel Manufacturing Equipment Market Size, with more than 18,000 units in operation. These systems reduce moisture content by 60% within 24 hours, ensuring product stability and shelf life. Around 52% of facilities use advanced tumble dryers, improving drying efficiency by 30%. Continuous drying systems have seen a 37% increase in adoption, reducing processing time by 25%. Energy-efficient systems lower energy consumption by 28%, enhancing operational sustainability.

• Other Auxiliary Devices: Auxiliary devices represent around 18% of the Softgel Manufacturing Equipment Industry Analysis, including polishing, sorting, and inspection systems. Approximately 46% of facilities deploy automated inspection equipment, improving quality control accuracy by 40%. Sorting machines enhance production efficiency by 35%, while polishing equipment improves product finish in 55% of cases. These devices are essential in maintaining compliance with quality standards. Around 33% of manufacturers integrate auxiliary systems with automated production lines.

By Application

Based on the application analysis, the soft-gel manufacturing equipment market is segmented into pharmaceuticals, health supplements, and others.

• Pharmaceutical: The pharmaceutical segment dominates with 52% of the Softgel Manufacturing Equipment Market Share, with over 70% of softgel capsules used for drug delivery. Approximately 65% of lipid-based drugs utilize softgel encapsulation, enhancing bioavailability by 30%. Around 48% of pharmaceutical companies invest in high-speed machines producing over 300,000 capsules per hour. Automation adoption in this segment exceeds 60%, improving consistency and reducing errors by 25%. Regulatory compliance drives 55% of equipment upgrades.

• Health Supplements: Health supplements account for 38% of the Softgel Manufacturing Equipment Market Size, with demand increasing by 44% over the past 5 years. Softgel capsules are used in 62% of vitamin and omega-3 products globally. Around 53% of supplement manufacturers rely on automated equipment to meet growing consumer demand. Production capacity has increased by 35% in large-scale facilities. Additionally, 41% of manufacturers are adopting plant-based encapsulation technologies.

• Others: Other applications contribute 10% to the Softgel Manufacturing Equipment Market Trends, including cosmetics and veterinary sectors. Around 29% of cosmetic products use softgel capsules for topical and ingestible formulations. Veterinary applications account for 21%, with increasing demand for encapsulated animal nutrition products. Approximately 34% of manufacturers in this segment use semi-automated systems. Equipment adoption in niche applications has grown by 27%, supporting diversified product development.

MARKET DYNAMICS

Driving Factor

Rising demand for pharmaceuticals

The increasing demand for pharmaceutical products accounts for nearly 68% of equipment utilization, with softgel dosage forms representing approximately 42% of oral drug delivery systems. Around 55% of newly approved lipid-based drugs require encapsulation technology, boosting demand for advanced equipment. Additionally, over 60% of pharmaceutical companies report higher production volumes of softgel capsules, with average annual output exceeding 120 million units per facility. The need for precise dosage and improved bioavailability has driven 47% of manufacturers to upgrade their machinery. This Softgel Manufacturing Equipment Market Growth is supported by the increasing prevalence of chronic diseases, affecting nearly 38% of the global population.

Restraining Factor

Demand for refurbished equipment

Approximately 49% of small-scale manufacturers prefer refurbished equipment due to cost savings of up to 40%, impacting new equipment sales. Around 44% of facilities in developing regions rely on second-hand machines, reducing demand for advanced systems. Maintenance costs for older machines are 30% higher, yet affordability remains a key factor. Additionally, 36% of buyers delay new purchases due to budget constraints. This trend limits technological adoption, as only 28% of refurbished systems support automation features. The Softgel Manufacturing Equipment Industry Analysis shows that cost-sensitive markets continue to hinder innovation adoption rates.

Growth in personalized medicines

Opportunity

Personalized medicine demand has increased by 51%, with softgel formats used in 33% of customized drug formulations. Approximately 46% of pharmaceutical companies are investing in flexible manufacturing systems to support small-batch production. Modular equipment adoption has grown by 39%, enabling production adjustments within 2 to 4 hours. Additionally, 42% of research facilities are using softgel encapsulation for targeted therapies. The rise of nutrigenomics has also driven a 37% increase in customized supplement production. These factors create strong Softgel Manufacturing Equipment Market Opportunities for innovation and expansion.

Rising costs and expenditures

Challenge

Raw material costs for equipment manufacturing have increased by 34%, impacting production expenses. Energy consumption accounts for nearly 22% of operational costs, while maintenance expenses contribute an additional 18%. Around 41% of manufacturers report challenges in maintaining profitability due to rising costs. Skilled labor shortages affect 29% of facilities, leading to reduced operational efficiency. Additionally, compliance with regulatory standards requires 26% more investment in validation processes. These challenges highlight constraints within the Softgel Manufacturing Equipment Market Outlook.

• Download Free Sample to learn more about this report

•  

SOFTGEL MANUFACTURING EQUIPMENT MARKET REGIONAL INSIGHTS

• North America

North America dominates the Softgel Manufacturing Equipment Market with approximately 34% market share and more than 9,000 installed machines across pharmaceutical and nutraceutical facilities. The United States contributes 82% of regional demand, while Canada accounts for 12% and Mexico 6%. Automation adoption exceeds 75%, improving production efficiency by nearly 40%. Around 58% of facilities operate high-speed encapsulation systems producing over 350,000 capsules per hour. Regulatory compliance standards influence 90% of equipment upgrades and replacements. Pharmaceutical applications account for 54% of equipment usage, while nutraceuticals contribute 46%, reflecting strong demand diversification.

• Europe

Europe holds around 24% of the Softgel Manufacturing Equipment Market Share, with Germany, France, and the UK collectively accounting for 68% of regional demand. Approximately 61% of manufacturers utilize advanced drying systems, improving operational efficiency by 28%. Automation adoption stands at 63%, while energy-efficient equipment usage has increased by 39% across facilities. Pharmaceutical applications dominate with 56% share, while health supplements account for 34%. Around 42% of production facilities upgraded their equipment between 2022 and 2024. Additionally, nearly 37% of manufacturers are integrating digital monitoring systems to enhance process control and reduce downtime.

• Asia-Pacific

Asia-Pacific represents nearly 31% of the Softgel Manufacturing Equipment Market Size, driven by strong demand from China, India, and Japan, which together contribute 74% of regional consumption. The region has over 12,000 installed machines, with 49% used in pharmaceutical production. Automation adoption stands at 52%, while demand for cost-effective equipment has increased by 46% among small and medium enterprises. Nutraceutical applications account for 41% of equipment usage, supported by rising health awareness among 38% of consumers. Production capacity has expanded by 33% in the past few years, reflecting growing industrial investments.

• Middle East & Africa

Middle East & Africa account for approximately 11% of the Softgel Manufacturing Equipment Market Outlook, with UAE, Saudi Arabia, and South Africa contributing 67% of regional demand. Around 44% of facilities operate semi-automated systems, while full automation adoption remains at 36%. Pharmaceutical applications dominate with 58% of equipment usage, while supplements contribute 32%. Equipment imports account for 73% of total supply, indicating reliance on international manufacturers. Infrastructure development initiatives have increased equipment adoption by 29%. Additionally, about 26% of facilities are transitioning toward automated systems to improve efficiency and production output.

LIST OF TOP SOFTGEL MANUFACTURING EQUIPMENT COMPANIES

• Changsung (South Korea)
• SKY (South Korea)
• Technophar (Canada)
• Pharmagel (U.S.)
• GIC Engineering (U.S.)
• Sankyo (Japan)
• Kamata (Japan)
• Bochang (South Korea)
• Tooltronics (India)
• Long March Tianmin (China)

Top Two Companies With The Highest Market Share

• Changsung: Changsung holds approximately 18%.

• Technophar: Technophar accounts for nearly 14%.

INVESTMENT ANALYSIS AND OPPORTUNITIES

Investment in the Softgel Manufacturing Equipment Market has increased significantly, with over 47% of manufacturers allocating funds toward automation upgrades. Approximately 39% of investments focus on energy-efficient technologies, reducing operational costs by 25%. Emerging markets account for 44% of new investments, particularly in Asia-Pacific and Latin America.

Private equity participation has grown by 28%, supporting equipment innovation and expansion. Around 51% of companies are investing in modular systems, enabling flexible production capacities. Additionally, 36% of investments target digitalization, including IoT and AI integration. These advancements improve operational efficiency by 33% and reduce downtime by 27%. The demand for sustainable solutions has driven 41% of investments into eco-friendly equipment. Furthermore, 48% of manufacturers are expanding production facilities, increasing output capacity by 30%. These Softgel Manufacturing Equipment Market Opportunities highlight strong potential for growth in automation and sustainability sectors.

NEW PRODUCT DEVELOPMENT

New product development in the Softgel Manufacturing Equipment Market is focused on automation and precision, with 62% of new equipment featuring advanced control systems. High-speed encapsulation machines now achieve production rates exceeding 400,000 capsules per hour, improving efficiency by 45%. Approximately 53% of new systems include real-time monitoring capabilities, reducing defects by 28%.

Manufacturers are developing equipment compatible with plant-based gelatin, addressing the 39% increase in vegan product demand. Energy-efficient designs reduce power consumption by 30%, while compact systems save 25% of floor space. Around 47% of new products incorporate modular designs, enabling flexible production configurations. Additionally, 35% of innovations focus on improving cleaning processes, reducing downtime by 20%. AI-based quality control systems are used in 29% of new equipment, enhancing inspection accuracy by 40%. These advancements contribute to improved productivity and operational efficiency.

FIVE RECENT DEVELOPMENTS (2023-2025)

• In 2023, 42% of manufacturers introduced automated encapsulation machines with production speeds exceeding 350,000 capsules per hour.
• In 2024, 36% of companies launched energy-efficient drying systems reducing energy consumption by 25%.
• In 2023, 31% of new equipment integrated IoT-based monitoring systems improving operational efficiency by 33%.
• In 2025, 28% of manufacturers introduced modular equipment designs allowing production flexibility within 4 hours.
• Between 2023 and 2025, 34% of companies developed plant-based gelatin-compatible machines supporting vegan product demand.

REPORT COVERAGE

The Softgel Manufacturing Equipment Market Report covers comprehensive analysis across 4 major regions and over 20 countries, representing 95% of global production capacity. The report includes data on more than 50 equipment manufacturers and over 100 product variants. Approximately 67% of the analysis focuses on automation trends, while 33% addresses traditional equipment usage.

The report evaluates 3 key equipment types and 3 major application segments, accounting for 100% of market demand distribution. Around 58% of the study emphasizes pharmaceutical applications, while 42% focuses on nutraceutical and other uses. Additionally, 45% of the report analyzes technological advancements, including IoT and AI integration. Production capacity analysis covers facilities producing over 300,000 capsules per hour, representing 62% of global output. The report also examines 5 years of historical data and current trends influencing 70% of market developments. It provides detailed insights into equipment efficiency, adoption rates, and regional distribution patterns.